metricas
covid
Neurología (English Edition) Compassionate use of human recombinant insulin-like growth factor-1 therapy in F...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Compassionate use of human recombinant insulin-like growth factor-1 therapy in Friedreich's ataxia
Utilidad del tratamiento como uso compasivo de mecasermina (factor de crecimiento insulínico recombinante humano tipo 1) en ataxia de Friedreich
A. García Rona,
Corresponding author
adrian.garciar@salud.madrid.org

Corresponding author.
, M. Rodriguez Mesab
a Unidad de Neuropediatría, Instituto del Niño y del Adolescente, Hospital Clínico San Carlos, Madrid, Spain
b Unidad de Cardiología Infantil, Servicio de Pediatría, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain
Read
2323
Times
was read the article
567
Total PDF
1756
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 19 6 25
2025 11 63 26 89
2025 10 54 12 66
2025 9 47 22 69
2025 8 45 11 56
2025 7 96 11 107
2025 6 72 10 82
2025 5 55 3 58
2025 4 46 11 57
2025 3 35 6 41
2025 2 47 2 49
2025 1 58 6 64
2024 12 26 1 27
2024 11 39 4 43
2024 10 21 5 26
2024 9 17 5 22
2024 8 19 2 21
2024 7 10 5 15
2024 6 16 3 19
2024 5 25 5 30
2024 4 29 10 39
2024 3 16 3 19
2024 2 21 6 27
2024 1 37 4 41
2023 12 29 10 39
2023 11 24 2 26
2023 10 39 7 46
2023 9 15 8 23
2023 8 16 9 25
2023 7 16 5 21
2023 6 25 3 28
2023 5 39 4 43
2023 4 31 2 33
2023 3 12 0 12
2023 2 17 5 22
2023 1 11 3 14
2022 12 38 8 46
2022 11 23 8 31
2022 10 12 10 22
2022 9 13 18 31
2022 8 20 7 27
2022 7 11 10 21
2022 6 17 6 23
2022 5 18 4 22
2022 4 13 11 24
2022 3 22 7 29
2022 2 7 6 13
2022 1 10 6 16
2021 12 8 6 14
2021 11 6 9 15
2021 10 14 11 25
2021 9 21 8 29
2021 8 15 8 23
2021 7 12 12 24
2021 6 10 10 20
2021 5 20 10 30
2021 4 41 22 63
2021 3 17 4 21
2021 2 15 5 20
2021 1 16 12 28
2020 12 14 8 22
2020 11 14 9 23
2020 10 9 6 15
2020 9 12 7 19
2020 8 18 9 27
2020 7 16 6 22
2020 6 11 8 19
2020 5 16 12 28
2020 4 11 9 20
2020 3 7 2 9
2020 2 6 4 10
2020 1 9 3 12
2019 12 13 15 28
2019 11 5 3 8
2019 10 4 1 5
2019 9 4 2 6
2019 8 1 8 9
Show all

Follow this link to access the full text of the article